Think of the Neurokinin-1 Antagonists as Equally Efficacious

January 2016

Rolapitant (Varubi) will compete with older neurokinin-1 antagonists to prevent chemotherapy-induced nausea and vomiting....

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

Medication Errors Help Standardize Stock In Operating Rooms
Infection Prevention Verify Catheters are Removed in Your PostOperative Patients
Hypertension Don't "SPRINT" to a Systolic BP Goal of < 120
Naloxone Verify That Patients Will Benefit From Topical NSAIDs at Discharge
Hepatitis C Watch Closely for Drug Interactions with Hep C Meds
Cardiology Tell Patients Clopidogrel Doesn't Increase Mortality
Antibiotics Limit Quinolone Use Due to Side Effects
Neurology Pain Verify That Patients Will Benefit From Topical NSAIDs at Discharge
Vaccines Don't Stop Statins in Patients Getting the Flu Vaccine
Asthma Give Single Dose Dexamethasone for Pediatric Asthma Exacerbations in the ED
Diabetes Use a 1:1 Ratio When Switching from Insulin Degludec to Glargine or Detemir
Hematology Oncology Think of the Neurokinin-1 Antagonists as Equally Efficacious